000 01599 a2200409 4500
005 20250512033043.0
264 0 _c19890206
008 198902s 0 0 eng d
022 _a0091-6749
024 7 _a10.1016/0091-6749(88)90139-x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAndersson, M
245 0 0 _aTopical glucocorticosteroids and allergen-induced increase in nasal reactivity: relationship between treatment time and inhibitory effect.
_h[electronic resource]
260 _bThe Journal of allergy and clinical immunology
_cDec 1988
300 _a1019-26 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdministration, Topical
650 0 4 _aAdult
650 0 4 _aAllergens
_xadministration & dosage
650 0 4 _aAnti-Inflammatory Agents
_xadministration & dosage
650 0 4 _aClinical Trials as Topic
650 0 4 _aDose-Response Relationship, Immunologic
650 0 4 _aDouble-Blind Method
650 0 4 _aFemale
650 0 4 _aGlucocorticoids
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aNasal Provocation Tests
650 0 4 _aRandom Allocation
650 0 4 _aRespiratory Hypersensitivity
_xdrug therapy
650 0 4 _aSneezing
_xdrug effects
650 0 4 _aTosylarginine Methyl Ester
_xmetabolism
700 1 _aAndersson, P
700 1 _aPipkorn, U
773 0 _tThe Journal of allergy and clinical immunology
_gvol. 82
_gno. 6
_gp. 1019-26
856 4 0 _uhttps://doi.org/10.1016/0091-6749(88)90139-x
_zAvailable from publisher's website
999 _c3066319
_d3066319